Veritone (VERI) 10-Q 9 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	Apr. 30, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Trading Symbol	VERI
Entity Registrant Name	Veritone, Inc.
Entity Central Index Key	0001615165
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-38093
Entity Tax Identification Number	47-1161641
Entity Address, Address Line One	2420 17th St.
Entity Address, Address Line Two	Office 3002
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	888
Local Phone Number	507-1737
Entity Common Stock, Shares Outstanding		36,067,923
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 237,553	$ 254,722
Accounts receivable, net	66,975	85,063
Expenditures billable to clients	19,693	27,180
Prepaid expenses and other current assets	12,519	12,117
Total current assets	336,740	379,082
Property, equipment and improvements, net	2,137	1,556
Intangible assets, net	86,563	88,247
Goodwill	36,630	34,058
Long-term restricted cash	856	855
Other assets	6,078	954
Total assets	469,004	504,752
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	38,345	46,711
Accrued media payments	96,327	86,923
Client advances	7,968	10,561
Contingent consideration, current	134	19,988
Other accrued liabilities	22,993	27,093
Total current liabilities	165,767	191,276
Convertible senior notes, non-current	195,381	195,082
Contingent consideration, non-current	35,416	24,737
Other non-current liabilities	16,440	13,078
Total liabilities	413,004	424,173
Commitments and contingencies (Note 9)
Stockholders' equity
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 36,056,839 and 34,972,256 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	36	35
Additional paid-in capital	435,954	431,606
Accumulated deficit	(380,076)	(350,958)
Accumulated other comprehensive income (loss)	86	(104)
Total stockholders' equity	56,000	80,579
Total liabilities and stockholders' equity	$ 469,004	$ 504,752

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	36,056,839	34,972,256
Common stock, shares outstanding	36,056,839	34,972,256

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 34,407	$ 18,295
Operating expenses:
Cost of revenue	6,923	4,823
Sales and marketing	11,069	6,427
Research and development	9,883	4,960
General and administrative	28,917	31,543
Amortization	4,693	1,078
Total operating expenses	61,485	48,831
Loss from operations	(27,078)	(30,536)
Other expense, net	(1,186)	(9)
Loss before provision for income taxes	(28,264)	(30,545)
Provision for income taxes	177	22
Net loss	$ (28,441)	$ (30,567)
Net loss per share:
Basic and diluted	$ (0.80)	$ (0.95)
Weighted average shares outstanding:
Basic and diluted	35,476,948	32,172,038
Comprehensive loss:
Net loss	$ (28,441)	$ (30,567)
Foreign currency translation gain, net of income taxes	190	7
Total comprehensive loss	$ (28,251)	$ (30,560)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative-effect of Accounting Change Adopted [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member]Cumulative-effect of Accounting Change Adopted [Member]	Accumulated Other Comprehensive Income [Member]
Beginning balance at Dec. 31, 2020	$ 88,210		$ 32	$ 368,477	$ (280,365)		$ 66
Beginning balance, shares at Dec. 31, 2020			31,799,354
Common stock issued under employee stock plans, net	4,254		$ 1	4,253
Common stock issued under employee stock plans, net, shares			608,886
Common stock issued for services	119			119
Common stock issued for services, shares			15,828
Stock-based compensation expense	21,491			21,491
Exercise of warrants	2,279		$ 2,279	2,279
Exercise of warrants, shares			252,218
Net loss	(30,567)				(30,567)
Other comprehensive gain (loss)	7						7
Ending balance at Mar. 31, 2021	85,793		$ 33	396,619	(310,932)		73
Ending balance, shares at Mar. 31, 2021			32,676,286
Beginning balance at Dec. 31, 2020	88,210		$ 32	368,477	(280,365)		66
Beginning balance, shares at Dec. 31, 2020			31,799,354
Net loss	(70,593)
Ending balance at Dec. 31, 2021	80,579	$ (677)	$ 35	431,606	(350,958)	$ (677)	(104)
Ending balance, shares at Dec. 31, 2021			34,972,256
Common stock issued under employee stock plans, net	570		$ 1	569
Common stock issued under employee stock plans, net, shares			1,073,543
Common stock withheld for employee taxes	(9,437)			(9,437)
Common stock withheld for employee taxes, shares			(457,840)
Common stock issued for acquisitions	1,929			1,929
Common stock issued for acquisitions, shares			116,550
Common stock issued as part of contingent consideration	6,440			6,440
Common stock issued as part of contingent consideration, shares			352,330
Stock-based compensation expense	4,847			4,847
Net loss	(28,441)				(28,441)
Other comprehensive gain (loss)	190						190
Ending balance at Mar. 31, 2022	$ 56,000		$ 36	$ 435,954	$ (380,076)		$ 86
Ending balance, shares at Mar. 31, 2022			36,056,839

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (28,441)	$ (30,567)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,891	1,253
Loss on disposal of fixed assets		1,894
Provision for doubtful accounts	194	5
Loss on sublease		1,211
Stock-based compensation expense	4,847	21,610
Change in fair value of contingent consideration	11,641
Change in deferred taxes	(426)
Amortization of debt issuance costs	299
Changes in assets and liabilities:
Accounts receivable	18,982	(7,439)
Expenditures billable to clients	7,487	2,236
Prepaid expenses and other assets	(18)	1,507
Other assets	(895)
Accounts payable	(8,384)	3,554
Accrued media payments	8,770	9,517
Client advances	(2,593)	1,825
Other accrued liabilities	(6,104)	(103)
Other liabilities	(116)	(294)
Net cash provided by operating activities	10,134	6,209	$ 7,234	$ 1,433
Cash flows from investing activities:
Minority investment	(2,000)
Capital expenditures	(735)	(100)
Acquisitions, net of cash acquired	(1,319)
Net cash used in investing activities	(4,054)	(100)
Cash flows from financing activities:
Payment of contingent considerations	(14,376)
Taxes paid related to net share settlement of equity awards	(9,441)
Proceeds from the exercise of warrants		2,279
Proceeds from issuances of stock under employee stock plans, net	569	4,254
Net cash (used in) provided by financing activities	(23,248)	6,533
Net (decrease) increase in cash and cash equivalents and restricted cash	(17,168)	12,642
Cash and cash equivalents and restricted cash, beginning of period	255,577	115,672	115,672
Cash and cash equivalents and restricted cash, end of period	238,409	$ 128,314	$ 255,577	$ 115,672
Non-cash activities:
Shares issued for acquisition of businesses and earn-out consideration	8,369
Lease liabilities arising from right-of-use assets	$ 4,501

Description of Business

Description of Business	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Description of Business	NOTE 1. DESCRIPTION OF BUSINESS Description of Business Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, collectively, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARE TM In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated Managed Services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds Network, which is comprised of programs that enable broadcasters, podcasters and social media influencers to generate incremental advertising revenue. The Company also offers cloud-native digital content management solutions and licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content. On March 1, 2022, the Company acquired an influencer-based management company, as discussed in more detail in Note 3.

Presentation and Summary of Sig

Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Presentation and Summary of Significant Accounting Policies	NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements. Liquidity and Capital Resources During the years ended December 31, 2021 and 2020, the Company generated cash flows from operations of $7,234 In 2022, driven by the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $237,553 as of March 31, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future. Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic and the war in Ukraine. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions. Significant Customers One individual customer accounted for 10% or more of the Company’s revenue for the three months ended March 31, 2022 and one individual customer accounted for 10% of the Company’s net revenues for the three months ended March 31, 2021. Remaining Performance Obligations As of March 31, 2022, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,798, approximately 57% This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations . Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders. Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, other than those associated with the recently adopted leasing guidance as further described in Note 9. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) more are treated. Under this guidance, lessees are required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or operating lease liability. On January 1, 2022, the Company adopted the new leasing standard using the modified retrospective transition method applied at the adoption date of the standard. See Note 9 for further details. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes Recently Issued Accounting Pronouncements In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers contract liability with the definition of a performance obligation. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its financial statements and related disclosures as well as the timing of adoption.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Business Combinations	NOTE 3. BUSINESS COMBINATIONS March 2022 Acquisition On March 1, 2022, the Company acquired 100% of an influencer-based management company, which is a California limited liability company, pursuant to a securities purchase agreement (the “Purchase Agreement”) dated as of March 1, 2022. The entity is an influencer management company that works with a select group of social media influencers to create content and custom marketing campaigns for brand partners and agencies. The total purchase consideration was $5,844 (the “Acquisition Consideration”), which consisted of upfront consideration of $1,500 in cash, $1,929 for the fair value of the Company’s 116,550 shares of common stock, and deferred cash payments to be made in 2023 and 2024 totaling $3,000, which was estimated to have a fair value of $2,707 on the acquisition date. The total purchase price was decreased by $976 for the settlement of a preexisting receivable and increased by $684 to adjust for the cash on hand at the time of the transaction closing. The total purchase consideration is preliminary and subject to net working capital adjustments that the Company expects to finalize and settle in the measurement period. In addition, the sellers may receive up to $4,500 in contingent earnout consideration based on achieving certain milestones tied to the entity’s financial performance in fiscal 2022 and 2023, which amount will be paid in cash (the “Earnout”). The fair value of the Earnout was estimated to be $3,015 as of March 1, 2022, all of which was deemed to be compensation to the seller which will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. The Company incurred $270 in acquisition-related expenses and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss. The following Acquisition consideration Preliminary Cash consideration at closing $ 1,500 Equity consideration at closing 1,929 Deferred consideration 2,707 Acquired cash 684 Settlement of pre-existing receivable (976 ) Total $ 5,844 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Preliminary purchase price allocation** Preliminary Cash $ 715 Accounts receivable 1,088 Prepaid and other current assets 120 Property and equipment 53 Intangible assets 3,000 Other assets 247 Total assets acquired 5,223 Accounts payable 18 Accrued expenses and other current liabilities 1,793 Operating lease liabilities, non-current 140 Total liabilities assumed 1,951 Identifiable net assets acquired $ 3,272 Goodwill 2,572 Total purchase consideration $ 5,844 **The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to opportunities to cross-sell into our Commercial Enterprise customer base. For income tax purposes, the Company elected to treat the transaction as an asset acquisition. Tax deductible goodwill generated from the acquisition is $2,842 (including transaction costs of $270). Identifiable Intangible Assets The identifiable intangible assets acquired consisted of the influencer network, trade name and brand relationships with estimated useful lives of 2 The fair value of the intangible assets has been estimated using an income approach. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates. The valuation of the intangible assets acquired along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Influencer network $ 1,500 5 Trade name 200 10 Brand relationships 1,300 5 Total intangible assets $ 3,000 PandoLogic Acquisition On September 14, 2021, the Company acquired 100% of PandoLogic., a company incorporated under the laws of the state of Israel, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of July 21, 2021. PandoLogic is a leading provider of intelligent hiring solutions and utilizes its proprietary platform to accelerate the time and improve the efficiency in the process for employers hiring at scale for both mass market and difficult-to-source candidates. PandoLogic’s fully autonomous recruiting platform helps employers source talent faster and more efficiently with predictive algorithms, machine learning and AI. The total purchase consideration for PandoLogic was $122,451 (the “Merger Consideration”), which consisted of upfront consideration of $58,733 in cash and $31,500 for the fair value of the Company’s 1,704,822 shares of common stock, up to $65,000 in contingent consideration based on achieving certain earnouts tied to financial performance of PandoLogic in fiscal 2021 and 2022, which amount will be paid in a combination of cash and common stock (the “Earnout”) and a net working capital adjustment of $5,818 paid in cash. The Company utilized a Monte Carlo simulation model to estimate the fair value of the Earnout. The fair value of the Earnout was estimated to be $30,000 as of September 14, 2021, $26,400 of which was deemed to be purchase consideration and recorded within contingent consideration current and contingent consideration non-current on the condensed consolidated balance sheet. The remaining $3,600 will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. Subsequent to the acquisition date, the Company is required to reassess its estimate of the fair value of the Earnout, including certain future Earnout obligations triggered on the employment status of certain PandoLogic management, and record any changes in earnings when the estimate is based on information not known as of the acquisition date (See Note 5). The Company incurred $2,161 in acquisition-related expenses in 2021 and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss The following Acquisition consideration Amount Cash consideration at closing $ 58,733 Equity consideration at closing 31,500 Contingent earnout 26,400 Net working capital adjustment 5,818 Total $ 122,451 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Purchase price allocation** Amount Cash $ 11,581 Accounts receivable 21,344 Prepaid and other current assets 8,710 Property and equipment 618 Intangible assets 86,000 Other assets 1,653 Total assets acquired 129,906 Accounts payable 13,183 Accrued expenses and other current liabilities 9,443 Deferred tax liability 11,828 Total liabilities assumed 34,454 Identifiable net assets acquired $ 95,452 Goodwill 26,999 Total purchase consideration $ 122,451 **The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to operational efficiencies from operating PandoLogic products on aiWARE as well as opportunities to cross-sell into our Commercial Enterprise customer base. Identifiable Intangible Assets The identifiable intangible assets acquired consisted of developed technology, customer relationships and tradename with estimated useful lives of 4 The fair value of the intangible assets has been estimated using a combination of the income and cost approaches. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates. Under the cost approach, the replacement cost is used to estimate the value of the asset. The key assumptions include the Company’s estimates of the direct and indirect costs required to replace the asset. The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships $ 68,000 5 - 7 Developed technology 16,000 4 Trade name 2,000 5 Total intangible assets $ 86,000 Taxes In connection with the acquisition, a net deferred tax liability of $11,828 was established primarily for the differences between the fair value of the acquired non-goodwill intangible assets and PandoLogic’s historical tax basis in these assets. No deferred tax asset or liability is recorded on PandoLogic goodwill, $25,141 of which is not deductible for tax purposes. In August 2021, PandoLogic obtained the approval for Preferred Technology Enterprise status under which its Israeli tax rate is reduced from the 23% statutory rate to a 12% beneficial rate. This arrangement is scheduled to expire in December 2025. The acquired Israel deferred tax assets and liabilities are computed based on the tax rate in the year of their expected reversal. No valuation allowance is recorded on the acquired PandoLogic deferred tax assets as it is more likely than not they will be utilized to offset future taxable income. Unaudited Pro Forma Results The unaudited pro forma financial information in the table below summarizes the combined results of operations for Veritone and PandoLogic as if the companies were combined for the three-month periods ended March 31, 2021. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including adjustments to reflect recognition of intangible asset amortization and accretion of contingent consideration. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of January 1, 2021. The unaudited pro forma financial information was as follows (in thousands): Three Months Ended March 31, 2021 Net revenue $ 23,794 Loss before provision for income taxes $ (36,069 ) Net loss $ (35,432 )

Debt

Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Debt	NOTE 4. DEBT Convertible Senior Notes In November 2021, the Company issued, at par value, $201.3 million aggregate principal amount of 1.75% convertible senior notes due 2026 (the “Convertible Notes”). The issuance included the full exercise of an option granted by the Company to the initial purchasers of the Convertible Notes to purchase an additional $26.25 million aggregate principal amount of Convertible Notes. The Convertible Notes were issued pursuant to and are subject to the terms and conditions of an indenture, which is referred to as the Indenture, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes were offered and sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The Convertible Notes are senior, unsecured obligations of the Company and will bear interest at a rate of 1.75% per year. Interest will accrue from November 19, 2021 and will be payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022. The Convertible Notes will mature on November 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible Notes. Holders of the Convertible Notes may convert all or any portion of their Convertible Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2026, only under the following conditions: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Convertible Notes on each such trading day; (3) if the Company calls such Convertible Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable redemption date; or (4) upon the occurrence of specified corporate events. On or after May 15, 2026, holders may convert all or any portion of their Convertible Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date regardless of the foregoing conditions. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election. The conversion rate for the Convertible Notes will initially be 27.2068 shares of the Company’s common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $36.76 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or following the Company’s issuance of a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event or who elects to convert its Convertible Notes called (or deemed called) for redemption during the related redemption period, as the case may be. The Company may not redeem the Convertible Notes prior to November 20, 2024. The Company may redeem for cash all or any portion of the Convertible Notes (subject to certain limitations), at its option, on or after November 20, 2024 if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Convertible Notes. If the Company undergoes a fundamental change prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their Convertible Notes. The fundamental change repurchase price will be equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Convertible Notes are the Company’s senior unsecured obligations and rank senior in right of payment to all of the Company’s indebtedness that is expressly subordinated in right of payment to the Convertible Notes; equal in right of payment with all existing and future liabilities of the Company that are not so subordinated; effectively junior to any of secured indebtedness of the Company to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) and any preferred equity of the Company’s current or future subsidiaries. The net proceeds from the issuance of the Convertible Notes were approximately $194.9 million, after deducting debt issuance costs. The total debt issuance costs incurred and recorded by the Company amounted to $6.3 million, which were recorded as a reduction to the face amount of the Convertible Notes and are being amortized to interest expense using the effective interest method over the contractual term of the Convertible Notes. The Convertible Notes are recorded as a liability within convertible senior notes, non-current. For the three months ended March 31, 2022, interest expense related to the Convertible Notes and amortization of the issuance costs was $1.2 million. The effective annual interest rate for the three months ended March 31, 2022 was approximately 2.42%. As of March 31, 2022, the if-converted value of the Convertible Notes did not exceed the outstanding principal amount. As of March 31, 2022, the total estimated fair value of the Convertible Notes was $176.3 million, which was determined based on a market approach using actual bids and offers of the Convertible Notes in an over-the-counter market on the last trading day of the period. The Company considers these assumptions to be Level 2 inputs in accordance with the fair value hierarchy described in Note 6. Capped Calls In connection with the pricing of the Convertible Notes, with the full exercise by the initial purchasers of their option to purchase additional Convertible Notes in November 2021, the Company used approximately $18.6 million of the net proceeds from the issuance of the Convertible Notes to enter into privately negotiated capped call transactions, which are referred to as the capped calls, with various financial institutions. The capped call transactions will cover, subject to anti-dilution adjustments substantially similar to those applicable to the Convertible Notes, the number of shares of the Company’s common stock underlying the Convertible Notes. The capped call transactions are expected generally to reduce the potential dilution to the Company’s common stock upon conversion of the Convertible Notes and/or offset some or all of any cash payments the Company is required to make in excess of the principal amount of converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions. The initial cap price of the capped calls is $48.55 per share of common stock, which represents a premium of 75% over the last reported sale price of the Company’s common stock of $27.74 per share on November 16, 2021, and is subject to certain customary adjustments under the terms of the capped calls; provided that the cap price will not be reduced to an amount less than the strike price of $35.76 per share. The capped call transactions are separate transactions and are not part of the terms of the Convertible Notes. The capped calls meet the criteria for classification as equity and, as such, are not remeasured each reporting period and are included as a reduction to additional paid-in-capital within stockholders’ equity.

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	NOTE 5. NET LOSS PER SHARE The following table presents the computation of basic and diluted net loss per share: Three Months Ended March 31, 2022 2021 Numerator Net loss $ (28,441 ) $ (30,567 ) Denominator Weighted-average common shares outstanding 35,478,676 32,191,419 Less: Weighted-average shares subject to repurchase (1,728 ) (19,381 ) Denominator for basic and diluted net loss per share attributable to common stockholders 35,476,948 32,172,038 Basic and diluted net loss per share $ (0.80 ) $ (0.95 ) The Company reported net losses for all periods presented and, as such, all potentially dilutive shares of common stock would have been antidilutive for such periods. The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended March 31, 2022 2021 Common stock options and restricted stock units 10,025,447 10,274,878 Warrants to purchase common stock 496,612 639,169 Common stock issuable in connection with convertible senior notes 5,475,369 — 15,997,428 10,914,047

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2022
Investments All Other Investments [Abstract]
Financial Instruments	NOTE 6. FINANCIAL INSTRUMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs that may be used to measure fair value. Level 1 and Level 2 are considered observable and Level 3 is considered unobservable, as follows: • Level 1—quoted prices (unadjusted) in active markets for identical assets or liabilities; • Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or • Level 3—unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Cash and Cash Equivalents The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of March 31, 2022, the Company’s cash and cash equivalents were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 236,524 $ — $ 236,524 $ 236,524 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 237,553 $ — $ 237,553 $ 237,553 As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 253,693 $ — $ 253,693 $ 253,693 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 254,722 $ — $ 254,722 $ 254,722 Contingent Consideration All of the Company’s contingent consideration liabilities are categorized as Level 3 within the fair value hierarchy. Contingent consideration for the PandoLogic acquisition was valued at the time of acquisition using Monte Carlo simulation models. These models incorporate contractual terms and assumptions regarding financial forecasts for PandoLogic, discount rates, and volatility of forecasted revenue. The value of the Company’s contingent consideration would increase if a lower discount rate was used and would decrease if a higher discount rate was used. Similarly, a higher revenue volatility assumption would increase the value of the contingent consideration, and a lower revenue volatility assumption would decrease the value of the contingent consideration. Contingent consideration for the March 2022 acquisition was valued using a simple probability of achievement model, with the probability of achievement based on management’s forecasted outcomes for 2022 and 2023 fiscal year results for the acquired entity. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Amount Paid Fair Contingent Cost Fair Value In Period Value Consideration Level 3: Contingent consideration, current $ 18,017 $ 2,933 $ (20,816 ) $ 134 $ 134 Contingent consideration, non-current 8,383 27,033 — 35,416 35,416 Total $ 26,400 $ 29,966 $ (20,816 ) $ 35,550 $ 35,550 As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Fair Contingent Cost Fair Value Value Consideration Level 3: Contingent consideration, current $ 18,017 $ 1,971 $ 19,988 $ 19,988 Contingent consideration, non-current 8,383 16,354 24,737 24,737 Total $ 26,400 $ 18,325 $ 44,725 $ 44,725 Stock Warrants All of the Company’s outstanding stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using either a probability weighted expected return model, the Monte Carlo simulation model or the Black-Scholes option-pricing model. These models incorporate contractual terms, maturity, risk-free interest rates and volatility. The value of the Company’s stock warrants would increase if a higher risk-free interest rate was used and would decrease if a lower risk-free interest rate was used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. Investments During the three months ended March 31, 2022, the Company invested $2,000 in a strategic investment in a technology company that was determined to not have a readily determinable fair value. This investment is carried initially at cost of $2,000 on our condensed consolidated balance sheet within other assets. The Company will monitor this investment to determine whether an other-than-temporary decline in value indicates that impairment charges may be required. The Company will also re-measure its investment if there is an observable transaction in a similar class of security to our investment.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	NOTE 7. GOODWILL AND INTANGIBLE ASSETS, NET Goodwill The carrying amount of goodwill was $36,630 as of March 31, 2022 and $34,058 December 31, 2021. Goodwill Balance at December 31, 2021 $ 34,058 March 2022 acquisition 2,572 Balance at March 31, 2022 $ 36,630 Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: March 31, 2022 December 31, 2021 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.0 $ 3,582 $ (3,555 ) $ 27 $ 3,582 $ (3,515 ) $ 67 Licensed technology 0.0 500 (500 ) — 500 (500 ) — Developed technology 3.1 25,600 (9,047 ) 16,553 25,600 (7,564 ) 18,036 Customer and supplier relationships 5.9 80,100 (12,173 ) 67,927 77,300 (9,157 ) 68,143 Noncompete agreements 0.3 800 (727 ) 73 800 (683 ) 117 Trade names 4.6 2,300 (317 ) 1,983 2,100 (216 ) 1,884 Total 5.4 $ 112,882 $ (26,319 ) $ 86,563 $ 109,882 $ (21,635 ) $ 88,247 The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2022: 2022 (9 months) $ 14,532 2023 17,891 2024 15,371 2025 13,788 2026 10,288 Thereafter 14,693 Total $ 86,563

Consolidated Financial Statemen

Consolidated Financial Statements Details	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Consolidated Financial Statements Details	NOTE 8. CONSOLIDATED FINANCIAL STATEMENTS DETAILS Consolidated Balance Sheets Details Cash and cash equivalents As of March 31, 2022 and December 31, 2021, the Company had cash and cash equivalents of $237,553 and $254,722, respectively, including $69,496 and $66,401, respectively, of cash received from advertising customers and content licensees for future payments to vendors. Accounts Receivable, Net Accounts receivable consisted of the following: As of March 31, December 31, 2022 2021 Accounts receivable — (1) $ 35,648 $ 21,347 Accounts receivable — (2) 25,847 59,568 Accounts receivable — 6,452 4,926 67,947 85,841 Less: allowance for doubtful accounts (972 ) (778 ) Accounts receivable, net $ 66,975 $ 85,063 (1) Accounts receivable – Managed Services reflects the amounts due from the Company’s advertising customers. (2) Accounts receivable – Software Products & Services reflects the amounts due from the Company’s PandoLogic customers. Property, Equipment and Improvements, Net Property, equipment and improvements, net consisted of the following: As of March 31, December 31, 2022 2021 Property and equipment $ 5,088 $ 4,262 Leasehold improvements 167 167 5,255 4,429 Less: accumulated depreciation (3,118 ) (2,873 ) Property, equipment and improvements, net $ 2,137 $ 1,556 Depreciation expense was $198 and $175 for the three months ended March 31, 2022 and 2021, respectively. Accounts Payable Accounts payable consisted of the following: As of March 31, December 31, 2022 2021 Accounts payable — (1) $ 27,440 $ 23,613 Accounts payable — 10,905 23,098 Total $ 38,345 $ 46,711 (1) Accounts payable – Managed Services reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients. Consolidated Statement of Operations and Comprehensive Loss Details Revenue Revenue for the periods presented were comprised of the following: Three Months Ended March 31, 2022 2021 Commercial Enterprise $ 33,626 $ 17,005 Government & Regulated Entities 781 1,290 Total revenue $ 34,407 $ 18,295 In the third quarter of fiscal year 2021, the Company realigned its organization to improve focus and growth into two customer groups: (1) Commercial Enterprise (“CE”), which today consists of customers in the commercial sector, including media and entertainment customers, advertising customers, content licensing customers and PandoLogic customers; and (2) Government & Regulated Industries (“GRI”), which today consists of customers in the government and regulated industries sectors, including state, local and federal government, legal, compliance and energy customers. Software Products & Services consists of revenue generated from the Company’s aiWARE platform and PandoLogic’s talent acquisition solutions, any related support and maintenance services, and any related professional services associated with the deployment and or implementation of such solutions. Managed Services consists of revenues generated from content licensing customers and advertising agency customers and related services. The table below illustrates the presentation of our revenues based on the above definitions: Three Months Ended March 31, 2022 Government & Commercial Regulated Enterprise Industries Total Total Software Products & Services (1) $ 17,386 $ 781 $ 18,167 Managed Services Advertising 10,968 — 10,968 Licensing 5,272 — 5,272 Total Managed Services 16,240 — 16,240 Total Revenue $ 33,626 $ 781 $ 34,407 (1) Software Products & Services consists of aiWARE revenues of $3,371 and PandoLogic revenues of $14,796. Three Months Ended March 31, 2021 Government & Commercial Regulated Enterprise Industries Total Total Software Products & Services $ 3,395 $ 1,290 $ 4,685 Managed Services Advertising 10,327 — 10,327 Licensing 3,283 — 3,283 Total Managed Services 13,610 — 13,610 Total Revenue $ 17,005 $ 1,290 $ 18,295 Other Expense, Net Other expense, net for the periods presented was comprised of the following: Three Months Ended March 31, 2022 2021 Interest (expense) income, net $ (1,182 ) $ 2 Other (4 ) (11 ) Other expense, net $ (1,186 ) $ (9 ) Provision for Income Taxes The provision or benefit from income taxes for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company records a cumulative adjustment. The income tax expense for the three months ended March 31, 2022 and 2021 resulted in an effective tax rate of (0.6)% and (0.1)%, respectively. The difference between the effective tax rate and the U.S. federal statutory rate is primarily due to a valuation allowance established on the majority of the Company’s federal and state net deferred tax assets and certain of its foreign operations. Due to tax losses and an offsetting valuation allowance against a majority of the U.S deferred tax assets, the Company recorded a tax provision in the amount of $177 for the three months ended March 31, 2022 as compared to $22 for the three months ended March 31, 2021. The increase is mainly attributed to the US and foreign income taxes resulted from the profitability of PandoLogic. As of March 31, 2022, the Company continues to provide a valuation allowance against certain federal and state deferred tax assets. The Company continues to evaluate the realizability of deferred tax assets and the related valuation allowance. If the Company’s assessment of the deferred tax assets or the corresponding valuation allowance were to change, the Company would record the related adjustment to income during the period in which the determination is made. The Company is subject to taxation in the U.S. and various foreign jurisdictions. The tax years subsequent to 2016 remain open and subject to examination by federal, state, and foreign taxing authorities in which the Company is subject to tax. The Company is not under examination in any other jurisdictions.

Leases, Commitments and Conting

Leases, Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Leases Commitments And Contingencies [Abstract]
Leases, Commitments and Contingencies	NOTE 9. LEASES, COMMITMENTS AND CONTINGENCIES Leases Adoption of the New Lease Accounting Standard On January 1, 2022, the Company adopted ASU No. 2016-02, Leases (Topic 842), using the modified retrospective transition method applied at the adoption date of the standard. Results for reporting periods beginning after January 1, 2022 are presented under the new leasing standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting. The Company has elected to utilize the package of practical expedients at the time of adoption, which allows the Company to (1) not reassess whether any expired or existing contracts are or contain leases, (2) not reassess the lease classification of any expired or existing leases, and (3) not reassess initial direct costs for any existing leases. The Company also has elected to utilize the short-term lease recognition exemption and, for those leases that qualified, the Company did not recognize right-of-use (“ROU”) assets or lease liabilities. As a result of adoption, the Company recorded ROU assets related to office facility leases which are recognized on the consolidated balance sheet within “other assets” and the associated lease liabilities are recognized on the consolidated balance sheet within “other accrued liabilities” and “other non-current liabilities.” The present value of the Company’s remaining lease payments, which comprise the lease liabilities, was estimated using the incremental borrowing rate as of the adoption date. The cumulative effects of the changes made to the Company’s January 1, 2022 consolidated balance sheet were as follows: December 31, 2021 Adjustments Due to Adoption of New Leasing Standard January 1, 2022 Assets Prepaid expenses and other current assets $ 12,117 $ 71 $ 12,188 Other assets 954 1,983 2,937 - Liabilities - Other accrued liabilities $ 27,093 $ 1,675 $ 28,768 Other non-current liabilities 13,078 1,057 14,135 - Stockholders' Equity - Accumulated deficit $ (350,958 ) $ (678 ) $ (351,636 ) New Lease Accounting Policies The Company determines if an arrangement is a lease at inception and determine the classification of the lease, as either operating or finance, at commencement. The Company has various operating leases for its offices. These existing leases have remaining lease terms ranging from 1 to 5 years 1 to 5 years ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the rate implicit in the Company’s leases is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company estimates the incremental borrowing rate to reflect the profile of secured borrowing over the expected term of the leases based on the information available at the later of the initial date of adoption or the lease commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives received at or before lease commencement. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Sublease rental income is recognized as a reduction to the related lease expense on a straight-line basis over the sublease term. Lease Costs As of March 31, 2022, on its condensed consolidated balance sheet the Company has right-of-use assets of $2,556 recorded within other assets, the current portion of operating lease liabilities of $2,106 recorded within other accrued liabilities, and the non-current portion of operating lease liabilities of $2,851 recorded within other non-current liabilities. The Company made cash payments for its operating leases of $652 for the three months ended March 31, 2022, all of which were included in cash flows from operating activities within the condensed consolidated statements of cash flows. The Company’s operating leases have a weighted average remaining lease term of 2.7 years and weighted average discount rate of 7.8%. In February 2021, the Company entered into an office sublease (the “Sublease”) with a third party (the “Subtenant”), pursuant to which the Company has subleased its former office space located in Costa Mesa, California, consisting of approximately 37,875 square feet, which the Company leases pursuant to an existing lease agreement expiring in 2024 (the “Lease”). The term of the Sublease commenced in March 2021 and will continue through December 31, 2024, coterminous with the Lease. Pursuant to the Sublease, the Subtenant will pay to the Company monthly base rent, which is subject to annual rent escalations, as well as a portion of the operating expenses and taxes payable by the Company under the Lease. The Company recognized contract termination costs as a liability when it ceased using the rights conveyed under the Lease. During the three months ended March 31, 2021, the Company recorded approximately $3,367 in charges resulting from the Sublease, consisting of $1,894 loss on disposal of property and equipment and leasehold improvements, The total rent expense for all operating leases, excluding the charges related to the Sublease discussed above, was $506 and $571 for the three months ended March 31, 2022 and 2021, respectively, with short-term leases making up an immaterial portion of such expenses. For its sublease, the Company recorded sublease income of $277 for the three months ended March 31, 2022. Lease Commitments Future undiscounted lease payments for the Company’s operating lease liabilities, a reconciliation of these payments to its operating lease liabilities, and related sublease income at December 31, 2021 are as follows: Years ended December 31, 2022 (nine months) $ 2,095 2023 2,241 2024 1,792 Total future minimum lease payments, including short-term leases 6,128 Less: future minimum lease payments for short-term leases (602 ) Less: imputed interest (569 ) Present value of future minimum lease payments, excluding short-term leases $ 4,957 Less: current portion of operating lease liabilities (2,106 ) Non-current portion of operating lease liabilities 2,851 Years ended December 31, Sublease Income 2022 (nine months) $ 782 2023 1,297 2024 1,034 Total sublease income $ 3,113 As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 under the previous lease accounting standard, future minimum lease payments at December 31, 2021, on an undiscounted basis, were as follows: 2022 $ 2,532 2023 2,091 2024 1,730 Total minimum payments $ 6,353 As of December 31, 2021, minimum sublease rental income to be received in the future under noncancelable subleases was approximately $3,402 and the total rent expense for all operating leases was $4,668 for the year ended December 31, 2021. Sales Taxes The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes tax nexus exists, which therefore obligates the Company to collect and remit sales tax. During the three months ended March 31, 2022 and 2021, the Company recorded a $134 liability and a $ liability, respectively, for potential exposure in several states where there is uncertainty about the point in time at which the Company established a sufficient business connection to create nexus. Purchase Consideration In connection with its March 2022 acquisition, the Company committed to make purchase consideration payments of $1,500 within ten days of the first anniversary of the closing date of the acquisition and an additional $1,500 within ten days of the second anniversary of the closing date of the acquisition. Refer to Note 3 for further details. Other Contingencies From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company currently is not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations, financial position or cash flows.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Stockholders' Equity	NOTE 10. STOCKHOLDERS’ EQUITY Common Stock Issuances During the three months ended March 31, 2022 and 2021, the Company issued an aggregate of 615,703 and 608,886 shares of its common stock, respectively, in connection with the exercise of stock options, issuance of stock awards and vesting of restricted stock units under its stock incentive plans and purchases under its Employee Stock Purchase Plan (the “ESPP”). During the three months ended March 31, 2022, the Company issued a total of 116,550 shares of its common stock in connection with its March 2022 acquisition. During the three months ended March 31, 2022, the Company issued a total of 352,330 shares of its common stock in connection with the contingent consideration arrangement related to the acquisition of PandoLogic. During the three months ended March 31, 2021, the Company issued a total of 167,495 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 84,723 shares of its common stock upon exercises of warrants to purchase an aggregate of 91,833 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price During the three months ended March 31, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company.

Stock Plans

Stock Plans	3 Months Ended
	Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Plans	NOTE 11. STOCK PLANS Stock-Based Compensation During the three months ended March 31, 2022, the Company granted options to purchase an aggregate of 480,850 shares of its common stock that are subject to time-based vesting conditions. The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2022: Expected term (in years) 6.1 Expected volatility 82 % Risk-free interest rate 1.8 % Expected dividend yield — The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2022 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 71% - 88% Risk-free interest rate 0.2% - 2.4% Expected dividend yield — The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended March 31, 2022 2021 Stock-based compensation expense by type of award: Restricted stock units $ 3,432 $ 4,171 Stock awards — 19 Performance-based stock options — 16,314 Stock options 1,273 837 Employee stock purchase plan 92 150 Common stock issued for services 19 119 Total $ 4,816 $ 21,610 Stock-based compensation expense by operating expense grouping: Cost of revenue $ 20 $ - Sales and marketing 463 898 Research and development 1,004 1,019 General and administrative 3,329 19,693 $ 4,816 $ 21,610 Equity Award Activity Under Stock Plans Restricted Stock Units The Company’s restricted stock unit activity for the three months ended March 31, 2022 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2021 886,461 $ 32.56 Granted 402,811 $ 16.47 Forfeited (28,824 ) $ 23.20 Vested (328,956 ) $ 46.65 Unvested at March 31, 2022 931,492 $ 21.01 As of March 31, 2022, total unrecognized compensation cost related to restricted stock units was $14,362, which is expected to be recognized over a weighted average period of 2.18 years. Performance-Based Stock Options The activity during the three months ended March 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2021 3,834,441 $ 11.05 Exercised (21,713 ) $ 5.55 Expired (7,277 ) $ 4.94 Outstanding at March 31, 2022 3,805,451 $ 11.09 6.3 $ 27,350 Exercisable at March 31, 2022 3,805,451 $ 11.09 6.3 $ 27,350 The aggregate intrinsic value of the options exercised during the three months ended March 31, 2022 and 2021 was $221 and $5,815, respectively. No performance-based stock options were granted during the three months ended March 31, 2022 and 2021 and no performance- based stock options vested during the three months ended March 31 , 202 2 . During the three months ended March 31, 2021, the Company achieved all of the stock price milestones applicable to substantially all of the performance-based stock options and, as a result, such performance-based stock options vested and all associated unrecognized compensation was accelerated and recognized in full as a one-time expense of $ 16,268 . Stock Options The activity during the three months ended March 31, 2022 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2021 5,508,608 $ 15.10 Granted 291,850 $ 16.13 Exercised (20,222 ) $ 7.33 Forfeited (57,134 ) $ 13.07 Expired (8,425 ) $ 21.61 Outstanding at March 31, 2022 5,714,677 $ 15.23 6.2 $ 25,419 Exercisable at March 31, 2022 4,289,264 $ 13.76 5.4 $ 20,201 The weighted average grant date fair value of stock options granted during the three months ended March 31, 2022 and 2021 was $11.36 and $32.68 per share, respectively. The aggregate intrinsic value of the stock options exercised during the three months ended March 31, 2022 and 2021 was $163 and $7,848 The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options. Employee Stock Purchase Plan During the three months ended March 31, 2022, a total of 67 shares of common stock were purchased under the Company’s ESPP. As of March 31, 2022, accrued employee contributions for future purchases under the ESPP totaled $191.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 12. RELATED PARTY TRANSACTIONS There were no related party transactions as of or during the three months ended March 31, 2022 and 2021.

Presentation and Summary of S_2

Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.
Liquidity and Capital Resources	Liquidity and Capital Resources During the years ended December 31, 2021 and 2020, the Company generated cash flows from operations of $7,234 In 2022, driven by the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $237,553 as of March 31, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future.
Use of Accounting Estimates	Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic and the war in Ukraine. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.
Significant Customers	Significant Customers One individual customer accounted for 10% or more of the Company’s revenue for the three months ended March 31, 2022 and one individual customer accounted for 10% of the Company’s net revenues for the three months ended March 31, 2021.
Remaining Performance Obligations	Remaining Performance Obligations As of March 31, 2022, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,798, approximately 57% This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations . Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders.
Significant Accounting Policies	Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, other than those associated with the recently adopted leasing guidance as further described in Note 9.
Recently Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) more are treated. Under this guidance, lessees are required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or operating lease liability. On January 1, 2022, the Company adopted the new leasing standard using the modified retrospective transition method applied at the adoption date of the standard. See Note 9 for further details. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes Recently Issued Accounting Pronouncements In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers contract liability with the definition of a performance obligation. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its financial statements and related disclosures as well as the timing of adoption.

Business Combinations (Tables)

Business Combinations (Tables)	3 Months Ended
	Mar. 31, 2022
March 2022 Acquisition [Member]
Summary of Preliminary Allocation of Purchase Consideration	The following Acquisition consideration Preliminary Cash consideration at closing $ 1,500 Equity consideration at closing 1,929 Deferred consideration 2,707 Acquired cash 684 Settlement of pre-existing receivable (976 ) Total $ 5,844 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Preliminary purchase price allocation** Preliminary Cash $ 715 Accounts receivable 1,088 Prepaid and other current assets 120 Property and equipment 53 Intangible assets 3,000 Other assets 247 Total assets acquired 5,223 Accounts payable 18 Accrued expenses and other current liabilities 1,793 Operating lease liabilities, non-current 140 Total liabilities assumed 1,951 Identifiable net assets acquired $ 3,272 Goodwill 2,572 Total purchase consideration $ 5,844
Summary of Valuation of Intangible Assets	The valuation of the intangible assets acquired along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Influencer network $ 1,500 5 Trade name 200 10 Brand relationships 1,300 5 Total intangible assets $ 3,000
Pandologic Ltd [Member]
Summary of Preliminary Allocation of Purchase Consideration	The following Acquisition consideration Amount Cash consideration at closing $ 58,733 Equity consideration at closing 31,500 Contingent earnout 26,400 Net working capital adjustment 5,818 Total $ 122,451 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Purchase price allocation** Amount Cash $ 11,581 Accounts receivable 21,344 Prepaid and other current assets 8,710 Property and equipment 618 Intangible assets 86,000 Other assets 1,653 Total assets acquired 129,906 Accounts payable 13,183 Accrued expenses and other current liabilities 9,443 Deferred tax liability 11,828 Total liabilities assumed 34,454 Identifiable net assets acquired $ 95,452 Goodwill 26,999 Total purchase consideration $ 122,451
Summary of Valuation of Intangible Assets	The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships $ 68,000 5 - 7 Developed technology 16,000 4 Trade name 2,000 5 Total intangible assets $ 86,000
Summary of Unaudited Proforma Information	The unaudited pro forma financial information was as follows (in thousands): Three Months Ended March 31, 2021 Net revenue $ 23,794 Loss before provision for income taxes $ (36,069 ) Net loss $ (35,432 )

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Loss Per Common Share	The following table presents the computation of basic and diluted net loss per share: Three Months Ended March 31, 2022 2021 Numerator Net loss $ (28,441 ) $ (30,567 ) Denominator Weighted-average common shares outstanding 35,478,676 32,191,419 Less: Weighted-average shares subject to repurchase (1,728 ) (19,381 ) Denominator for basic and diluted net loss per share attributable to common stockholders 35,476,948 32,172,038 Basic and diluted net loss per share $ (0.80 ) $ (0.95 )
Effect of Anti-dilutive Securities	The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended March 31, 2022 2021 Common stock options and restricted stock units 10,025,447 10,274,878 Warrants to purchase common stock 496,612 639,169 Common stock issuable in connection with convertible senior notes 5,475,369 — 15,997,428 10,914,047

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2022
Investments All Other Investments [Abstract]
Schedule of Cash and Cash Equivalents	As of March 31, 2022, the Company’s cash and cash equivalents were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 236,524 $ — $ 236,524 $ 236,524 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 237,553 $ — $ 237,553 $ 237,553 As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 253,693 $ — $ 253,693 $ 253,693 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 254,722 $ — $ 254,722 $ 254,722
Schedule of Contingent Consideration Liabilities Current and Non-current Balances	As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Amount Paid Fair Contingent Cost Fair Value In Period Value Consideration Level 3: Contingent consideration, current $ 18,017 $ 2,933 $ (20,816 ) $ 134 $ 134 Contingent consideration, non-current 8,383 27,033 — 35,416 35,416 Total $ 26,400 $ 29,966 $ (20,816 ) $ 35,550 $ 35,550 As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Fair Contingent Cost Fair Value Value Consideration Level 3: Contingent consideration, current $ 18,017 $ 1,971 $ 19,988 $ 19,988 Contingent consideration, non-current 8,383 16,354 24,737 24,737 Total $ 26,400 $ 18,325 $ 44,725 $ 44,725

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Carrying Amount of Goodwill	The carrying amount of goodwill was $36,630 as of March 31, 2022 and $34,058 December 31, 2021. Goodwill Balance at December 31, 2021 $ 34,058 March 2022 acquisition 2,572 Balance at March 31, 2022 $ 36,630
Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases	The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: March 31, 2022 December 31, 2021 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.0 $ 3,582 $ (3,555 ) $ 27 $ 3,582 $ (3,515 ) $ 67 Licensed technology 0.0 500 (500 ) — 500 (500 ) — Developed technology 3.1 25,600 (9,047 ) 16,553 25,600 (7,564 ) 18,036 Customer and supplier relationships 5.9 80,100 (12,173 ) 67,927 77,300 (9,157 ) 68,143 Noncompete agreements 0.3 800 (727 ) 73 800 (683 ) 117 Trade names 4.6 2,300 (317 ) 1,983 2,100 (216 ) 1,884 Total 5.4 $ 112,882 $ (26,319 ) $ 86,563 $ 109,882 $ (21,635 ) $ 88,247
Summary of Future Amortization of Finite-Lived Intangible Assets	The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2022: 2022 (9 months) $ 14,532 2023 17,891 2024 15,371 2025 13,788 2026 10,288 Thereafter 14,693 Total $ 86,563

Consolidated Financial Statem_2

Consolidated Financial Statements Details (Tables)	3 Months Ended
	Mar. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Summary of Accounts Receivable, Net	Accounts receivable consisted of the following: As of March 31, December 31, 2022 2021 Accounts receivable — (1) $ 35,648 $ 21,347 Accounts receivable — (2) 25,847 59,568 Accounts receivable — 6,452 4,926 67,947 85,841 Less: allowance for doubtful accounts (972 ) (778 ) Accounts receivable, net $ 66,975 $ 85,063 (1) Accounts receivable – Managed Services reflects the amounts due from the Company’s advertising customers. (2) Accounts receivable – Software Products & Services reflects the amounts due from the Company’s PandoLogic customers.
Summary of Property Equipment and Improvements, Net	Property, equipment and improvements, net consisted of the following: As of March 31, December 31, 2022 2021 Property and equipment $ 5,088 $ 4,262 Leasehold improvements 167 167 5,255 4,429 Less: accumulated depreciation (3,118 ) (2,873 ) Property, equipment and improvements, net $ 2,137 $ 1,556
Summary of Accounts Payable	Accounts payable consisted of the following: As of March 31, December 31, 2022 2021 Accounts payable — (1) $ 27,440 $ 23,613 Accounts payable — 10,905 23,098 Total $ 38,345 $ 46,711 (1) Accounts payable – Managed Services reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients.
Summary of Revenue	Revenue for the periods presented were comprised of the following: Three Months Ended March 31, 2022 2021 Commercial Enterprise $ 33,626 $ 17,005 Government & Regulated Entities 781 1,290 Total revenue $ 34,407 $ 18,295
Summary of Presentation of Revenues	The table below illustrates the presentation of our revenues based on the above definitions: Three Months Ended March 31, 2022 Government & Commercial Regulated Enterprise Industries Total Total Software Products & Services (1) $ 17,386 $ 781 $ 18,167 Managed Services Advertising 10,968 — 10,968 Licensing 5,272 — 5,272 Total Managed Services 16,240 — 16,240 Total Revenue $ 33,626 $ 781 $ 34,407 (1) Software Products & Services consists of aiWARE revenues of $3,371 and PandoLogic revenues of $14,796. Three Months Ended March 31, 2021 Government & Commercial Regulated Enterprise Industries Total Total Software Products & Services $ 3,395 $ 1,290 $ 4,685 Managed Services Advertising 10,327 — 10,327 Licensing 3,283 — 3,283 Total Managed Services 13,610 — 13,610 Total Revenue $ 17,005 $ 1,290 $ 18,295
Schedule of Other Expense, Net	Other expense, net for the periods presented was comprised of the following: Three Months Ended March 31, 2022 2021 Interest (expense) income, net $ (1,182 ) $ 2 Other (4 ) (11 ) Other expense, net $ (1,186 ) $ (9 )

Leases, Commitments and Conti_2

Leases, Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2022
Leases Commitments And Contingencies [Abstract]
Schedule of Cumulative Effects of Changes Made to the Company	The cumulative effects of the changes made to the Company’s January 1, 2022 consolidated balance sheet were as follows: December 31, 2021 Adjustments Due to Adoption of New Leasing Standard January 1, 2022 Assets Prepaid expenses and other current assets $ 12,117 $ 71 $ 12,188 Other assets 954 1,983 2,937 - Liabilities - Other accrued liabilities $ 27,093 $ 1,675 $ 28,768 Other non-current liabilities 13,078 1,057 14,135 - Stockholders' Equity - Accumulated deficit $ (350,958 ) $ (678 ) $ (351,636 )
Summary of Future Minimum Lease Payments	Future undiscounted lease payments for the Company’s operating lease liabilities, a reconciliation of these payments to its operating lease liabilities, and related sublease income at December 31, 2021 are as follows: Years ended December 31, 2022 (nine months) $ 2,095 2023 2,241 2024 1,792 Total future minimum lease payments, including short-term leases 6,128 Less: future minimum lease payments for short-term leases (602 ) Less: imputed interest (569 ) Present value of future minimum lease payments, excluding short-term leases $ 4,957 Less: current portion of operating lease liabilities (2,106 ) Non-current portion of operating lease liabilities 2,851 Years ended December 31, Sublease Income 2022 (nine months) $ 782 2023 1,297 2024 1,034 Total sublease income $ 3,113 As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 under the previous lease accounting standard, future minimum lease payments at December 31, 2021, on an undiscounted basis, were as follows: 2022 $ 2,532 2023 2,091 2024 1,730 Total minimum payments $ 6,353

Stock Plans (Tables)

Stock Plans (Tables)	3 Months Ended
	Mar. 31, 2022
Schedule of Stock-based Compensation Expense	The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended March 31, 2022 2021 Stock-based compensation expense by type of award: Restricted stock units $ 3,432 $ 4,171 Stock awards — 19 Performance-based stock options — 16,314 Stock options 1,273 837 Employee stock purchase plan 92 150 Common stock issued for services 19 119 Total $ 4,816 $ 21,610 Stock-based compensation expense by operating expense grouping: Cost of revenue $ 20 $ - Sales and marketing 463 898 Research and development 1,004 1,019 General and administrative 3,329 19,693 $ 4,816 $ 21,610
Schedule of Restricted Stock Unit Activity	The Company’s restricted stock unit activity for the three months ended March 31, 2022 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2021 886,461 $ 32.56 Granted 402,811 $ 16.47 Forfeited (28,824 ) $ 23.20 Vested (328,956 ) $ 46.65 Unvested at March 31, 2022 931,492 $ 21.01
Schedule of Stock Option Activity	The activity during the three months ended March 31, 2022 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2021 5,508,608 $ 15.10 Granted 291,850 $ 16.13 Exercised (20,222 ) $ 7.33 Forfeited (57,134 ) $ 13.07 Expired (8,425 ) $ 21.61 Outstanding at March 31, 2022 5,714,677 $ 15.23 6.2 $ 25,419 Exercisable at March 31, 2022 4,289,264 $ 13.76 5.4 $ 20,201
Employee Stock Purchase Plan [Member]
Summary of Fair Value Assumptions of Stock Purchase Plan	The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2022 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 71% - 88% Risk-free interest rate 0.2% - 2.4% Expected dividend yield —
Stock Options [Member]
Schedule of Fair Value Assumptions	The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2022: Expected term (in years) 6.1 Expected volatility 82 % Risk-free interest rate 1.8 % Expected dividend yield —
Performance-based Stock Options [Member]
Schedule of Stock Option Activity	The activity during the three months ended March 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2021 3,834,441 $ 11.05 Exercised (21,713 ) $ 5.55 Expired (7,277 ) $ 4.94 Outstanding at March 31, 2022 3,805,451 $ 11.09 6.3 $ 27,350 Exercisable at March 31, 2022 3,805,451 $ 11.09 6.3 $ 27,350

Presentation and Summary of S_3

Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022USD ($)Customer	Mar. 31, 2021USD ($)Customer	Dec. 31, 2021USD ($)Customer	Dec. 31, 2020USD ($)	Jan. 01, 2022USD ($)
Significant Accounting Policies [Line Items]
Positive (negative) cash flows from operations	$ 10,134	$ 6,209	$ 7,234	$ 1,433
Net loss	28,441	30,567	70,593	$ 47,876
Accumulated deficit	380,076		350,958		$ 351,636
Proceeds from issuances of stock under employee stock plans, net	569	4,254
Tax paid related to net share settlement of equity awards	9,441
Cash and cash equivalents	237,553	$ 237,553	$ 254,722
Transaction price remaining performance obligations	$ 8,798
Transaction price remaining performance obligations percentage	57.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer	1	1
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage	10.00%	10.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer		2	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage		10.00%	10.00%
Pandologic Ltd [Member]
Significant Accounting Policies [Line Items]
Earnout payment	$ 14,376

Presentation and Summary of S_4

Presentation and Summary of Significant Accounting Policies - Additional Information (Details 1)	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Significant Accounting Policies [Line Items]
Expected Recognition of revenue over remaining contract terms	12 months

Business Combinations - Additio

Business Combinations - Additional Information (Detail) - USD ($)	Mar. 01, 2022	Sep. 14, 2021	Mar. 31, 2022	Dec. 31, 2021
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total consideration	$ 5,844,000
Equity consideration at closing	1,929,000
Deferred consideration	2,707,000
Settlement of pre-existing receivable	976,000
Acquired cash	684,000
Contingent earnout	3,015,000
Tax deductible goodwill, acquisition	2,842,000
Transaction cost	270,000
March 2022 Acquisition [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Acquisition related expenses	$ 270,000
March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives	10 years
March 2022 Acquisition [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives	2 years
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Contingent earnout		$ 30,000,000
Pandologic Ltd [Member] | Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout		26,400,000
Pandologic Ltd [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Acquisition related expenses				$ 2,161,000
Pandologic Ltd [Member] | Recognized in Compensation Expense Within General and Administrative Expense [Member]
Business Acquisition [Line Items]
Contingent earnout		3,600,000
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total consideration		122,451,000
Equity consideration at closing		31,500,000
Deferred tax liability		$ 11,828,000	$ 0
Deferred tax assets			0
Goodwill not deductible for tax purposes			25,141,000
Deferred tax assets, valuation allowance			$ 0
Pandologic Ltd [Member] | Israeli [Member]
Business Acquisition [Line Items]
Tax rate		23.00%	12.00%
Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives			7 years
Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives			4 years
Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Consideration equity interest issued number of shares			352,330
Purchase Agreement [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Business acquisition, effective date of acquisition	Mar. 1, 2022
Business acquisition, percentage of ownership interests acquired	100.00%
Business acquisition, date of acquisition agreement	Mar. 1, 2022
Total consideration	$ 5,844,000
Consideration upfront payment in cash	1,500,000
Deferred cash payment	3,000,000
Deferred consideration	2,707,000
Settlement of pre-existing receivable	(976,000)
Acquired cash	684,000
Purchase Agreement [Member] | March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Contingent earnout consideration	4,500,000
Purchase Agreement [Member] | March 2022 Acquisition [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration at closing	$ 1,929,000
Consideration equity interest issued number of shares	116,550
Merger Agreement [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Business acquisition, effective date of acquisition		Sep. 14, 2021
Business acquisition, percentage of ownership interests acquired		100.00%
Business acquisition, date of acquisition agreement		Jul. 21, 2021
Total consideration		$ 122,451,000
Consideration upfront payment in cash		$ 58,733,000
Business acquisition, name of acquired entity		PandoLogic.
Merger Agreement [Member] | Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Contingent earnout consideration		$ 65,000,000
Merger Agreement [Member] | Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration at closing		$ 31,500,000
Consideration equity interest issued number of shares		1,704,822

Business Combinations - Summary

Business Combinations - Summary of Fair Value of Purchase Price Consideration (Details) - USD ($) $ in Thousands	Mar. 01, 2022	Sep. 14, 2021
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Cash consideration at closing	$ 1,500
Equity consideration at closing	1,929
Deferred consideration	2,707
Acquired cash	684
Settlement of pre-existing receivable	(976)
Total	$ 5,844
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Cash consideration at closing		$ 58,733
Equity consideration at closing		31,500
Net working capital adjustment		5,818
Total		122,451
Pandologic Ltd [Member] | Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout		$ 26,400

Business Combinations - Summa_2

Business Combinations - Summary of Preliminary Allocation of Purchase Consideration (Details) - USD ($)	Mar. 31, 2022	Mar. 01, 2022	Dec. 31, 2021	Sep. 14, 2021
Business Acquisition [Line Items]
Goodwill	$ 36,630,000		$ 34,058,000
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Cash		$ 715,000
Accounts receivable		1,088,000
Prepaid and other current assets		120,000
Property and equipment		53,000
Intangible assets		3,000,000
Other assets		247,000
Total assets acquired		5,223,000
Accounts payable		18,000
Accrued expenses and other current liabilities		1,793,000
Operating lease liabilities, non-current		140,000
Total liabilities assumed		1,951,000
Identifiable net assets acquired		3,272,000
Goodwill		2,572,000
Total purchase consideration		$ 5,844,000
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Cash				$ 11,581,000
Accounts receivable				21,344,000
Prepaid and other current assets				8,710,000
Property and equipment				618,000
Intangible assets				86,000,000
Other assets				1,653,000
Total assets acquired				129,906,000
Accounts payable				13,183,000
Accrued expenses and other current liabilities				9,443,000
Deferred tax liability	$ 0			11,828,000
Total liabilities assumed				34,454,000
Identifiable net assets acquired				95,452,000
Goodwill				26,999,000
Total purchase consideration				$ 122,451,000

Business Combinations - Summa_3

Business Combinations - Summary of Valuation of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 01, 2022	Sep. 14, 2021	Mar. 31, 2022
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 3,000
March 2022 Acquisition [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives	2 years
March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives	10 years
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 86,000
Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives			4 years
Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives			7 years
Influencer Network [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 1,500
Estimated useful lives	5 years
Customer Relationships [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 68,000
Customer Relationships [Member] | Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives		5 years
Customer Relationships [Member] | Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives		7 years
Trade Name [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 200
Estimated useful lives	10 years
Trade Name [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 2,000
Estimated useful lives		5 years
Developed Technology [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 16,000
Estimated useful lives		4 years
Brand Relationships [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 1,300
Estimated useful lives	5 years

Business Combinations - Summa_4

Business Combinations - Summary of Unaudited Proforma Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)
Business Combinations [Abstract]
Net revenue	$ 23,794
Loss before provision for income taxes	(36,069)
Net loss	$ (35,432)

Debt - Additional Information (

Debt - Additional Information (Detail)	1 Months Ended	3 Months Ended
	Nov. 30, 2021USD ($)Day$ / shares	Mar. 31, 2022USD ($)$ / Derivative	Nov. 16, 2021$ / shares
Debt Instrument [Line Items]
Amortization of debt issuance costs		$ 299,000
Payment for capped call transactions	$ 18,600,000
Initial cap price | $ / Derivative		48.55
Premium over last reported sale price, percentage	75.00%
Sale price of common stock | $ / shares			$ 27.74
Strike price | $ / Derivative		35.76
1.75% Convertible Senior Notes Due 2026 [Member]
Debt Instrument [Line Items]
Aggregate principal amount	$ 201,300
Debt instrument, interest rate	1.75%	1.75%
Additional principal amount	$ 26,250,000
Debt instrument, frequency of periodic payment		semi-annually
Debt instrument, payment terms		will be payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022.
Debt Instrument, maturity date, description		The Convertible Notes will mature on November 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible Notes.
Debt Instrument, maturity date		Nov. 15, 2026
Number of trading days (whether or not consecutive) | Day	20
Number of consecutive trading days | Day	30
Percentage of conversion price	130.00%
Debt instrument convertible measurement period	5 years
Debt instrument convertible business period	5 years
Debt instrument convertible principal amount	$ 1,000,000
Debt instrument convertible measurement period percentage	98.00%
Debt instrument, convertible, Date	May 15, 2026
Initial conversion rate	0.0272068
Initial conversion price | $ / shares	$ 36.76
Redemption date	Nov. 20, 2024
Percentage of conversion stock price, Redemption	130.00%
Debt instrument, Redeemable, Number of trading days | Day	20
Debt instrument, Redeemable, Number of consecutive trading days | Day	30
Redemption price, Percentage of principal amount to be redeemed	100.00%
Sinking fund	$ 0
Debt instrument repurchase price due to fundamental change	100.00%
Net proceeds from issuance of notes		$ 194,900,000
Debt issuance costs		6,300,000
Amortization of debt issuance costs		1,200,000
Interest expense		$ 1,200,000
Effective annual interest rate		2.42%
Convertible debt, if-converted value in excess of principal		$ 0
Estimated fair value of convertible notes		$ 176,300,000

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Numerator
Net loss	$ (28,441)	$ (30,567)	$ (70,593)	$ (47,876)
Denominator
Weighted-average common shares outstanding	35,478,676	32,191,419
Less: Weighted-average shares subject to repurchase	(1,728)	(19,381)
Denominator for basic and diluted net loss per share attributable to common stockholders	35,476,948	32,172,038
Basic and diluted net loss per share	$ (0.80)	$ (0.95)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Anti-dilutive Securities (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	15,997,428	10,914,047
Employee Stock Option and Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	10,025,447	10,274,878
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	496,612	639,169
Common Stock Issuable in Connection with Convertible Senior Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	5,475,369

Financial Instruments - Schedul

Financial Instruments - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Schedule Of Available For Sale Securities [Line Items]
Total Cash and Debt Securities	$ 237,553	$ 254,722
Total Fair Value, Cash and Debt Securities	237,553	254,722
Cash and cash equivalents	237,553	254,722	$ 237,553
Cash [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	236,524	253,693
Fair Value, Cash	236,524	253,693
Level 1 [Member] | Money Market Funds [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	1,029	1,029
Cash and cash equivalents gross before unrealized losses	1,029	1,029
Fair Value, Cash	$ 1,029	$ 1,029

Financial Instruments - Sched_2

Financial Instruments - Schedule of Contingent Consideration Liabilities Current and Non-current Balances (Details) - Level 3 [Member] - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Contingent Consideration Liabilities [Line Items]
Cost	$ 26,400	$ 26,400
Changes in Fair Value	29,966	18,325
Amount Paid In Period	(20,816)
Fair Value	35,550	44,725
Contingent Consideration	35,550	44,725
Contingent Consideration, Current [Member]
Contingent Consideration Liabilities [Line Items]
Cost	18,017	18,017
Changes in Fair Value	2,933	1,971
Amount Paid In Period	(20,816)
Fair Value	134	19,988
Contingent Consideration	134	19,988
Contingent Consideration, Noncurrent [Member]
Contingent Consideration Liabilities [Line Items]
Cost	8,383	8,383
Changes in Fair Value	27,033	16,354
Fair Value	35,416	24,737
Contingent Consideration	$ 35,416	$ 24,737

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) $ in Thousands	Mar. 31, 2022USD ($)
Other Assets
Schedule Of Available For Sale Securities [Line Items]
Strategic investment	$ 2,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Carrying amount of goodwill	$ 36,630	$ 34,058

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Schedule of Carrying Amount of Goodwill (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Impairment Of Intangible Assets Excluding Goodwill [Abstract]
Beginning balance	$ 34,058
March 2022 acquisition	2,572
Ending balance	$ 36,630

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years 4 months 24 days
Gross Carrying Amount	$ 112,882	$ 109,882
Accumulated Amortization	(26,319)	(21,635)
Net Carrying Amount	$ 86,563	88,247
Software and Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	0 years
Gross Carrying Amount	$ 3,582	3,582
Accumulated Amortization	(3,555)	(3,515)
Net Carrying Amount	$ 27	67
Licensed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	0 years
Gross Carrying Amount	$ 500	500
Accumulated Amortization	$ (500)	(500)
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 years 1 month 6 days
Gross Carrying Amount	$ 25,600	25,600
Accumulated Amortization	(9,047)	(7,564)
Net Carrying Amount	$ 16,553	18,036
Customer and Supplier Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years 10 months 24 days
Gross Carrying Amount	$ 80,100	77,300
Accumulated Amortization	(12,173)	(9,157)
Net Carrying Amount	$ 67,927	68,143
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 months 18 days
Gross Carrying Amount	$ 800	800
Accumulated Amortization	(727)	(683)
Net Carrying Amount	$ 73	117
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	4 years 7 months 6 days
Gross Carrying Amount	$ 2,300	2,100
Accumulated Amortization	(317)	(216)
Net Carrying Amount	$ 1,983	$ 1,884

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Summary of Future Amortization of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2022 (9 months)	$ 14,532
2023	17,891
2024	15,371
2025	13,788
2026	10,288
Thereafter	14,693
Net Carrying Amount	$ 86,563	$ 88,247

Consolidated Financial Statem_3

Consolidated Financial Statements Details - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 237,553	$ 237,553	$ 254,722
Depreciation Expense	$ 198	$ 175
Effective tax rate	(0.60%)	(0.10%)
Provision for income taxes	$ 177	$ 22
Advertising Customers and Content Licensees [Member]
Condensed Financial Statements, Captions [Line Items]
Cash received	$ 69,496		$ 66,401

Consolidated Financial Statem_4

Consolidated Financial Statements Details - Summary of Accounts Receivable,Net (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts receivable, gross	$ 67,947	$ 85,841
Less: allowance for doubtful accounts	(972)	(778)
Accounts receivable, net	66,975	85,063
Managed Services [Member]
Accounts receivable, gross	35,648	21,347
Software Products & Services [Member]
Accounts receivable, gross	25,847	59,568
Other [Member]
Accounts receivable, gross	$ 6,452	$ 4,926

Consolidated Financial Statem_5

Consolidated Financial Statements Details - Summary of Property Equipment and Improvements, Net (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Abstract]
Property and equipment	$ 5,088	$ 4,262
Leasehold improvements	167	167
Property, equipment and improvements, gross	5,255	4,429
Less: accumulated depreciation	(3,118)	(2,873)
Property, equipment and improvements, net	$ 2,137	$ 1,556

Consolidated Financial Statem_6

Consolidated Financial Statements Details - Accounts Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Accounts payable — Managed Services	$ 27,440	$ 23,613
Accounts payable — Other	10,905	23,098
Total	$ 38,345	$ 46,711

Consolidated Financial Statem_7

Consolidated Financial Statements Details - Summary of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 34,407	$ 18,295
Commercial Enterprise [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	33,626	17,005
Government and Regulated Entities [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 781	$ 1,290

Consolidated Financial Statem_8

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 34,407	$ 18,295
Commercial Enterprise [Member]
Revenue	33,626	17,005
Government and Regulated Industries [Member]
Revenue	781	1,290
Software Products & Services [Member]
Revenue	18,167	4,685
Software Products & Services [Member] | Commercial Enterprise [Member]
Revenue	17,386	3,395
Software Products & Services [Member] | Government and Regulated Industries [Member]
Revenue	781	1,290
Advertising [Member]
Revenue	10,968	10,327
Advertising [Member] | Commercial Enterprise [Member]
Revenue	10,968	10,327
Licensing [Member]
Revenue	5,272	3,283
Licensing [Member] | Commercial Enterprise [Member]
Revenue	5,272	3,283
Total Managed Services [Member]
Revenue	16,240	13,610
Total Managed Services [Member] | Commercial Enterprise [Member]
Revenue	$ 16,240	$ 13,610

Consolidated Financial Statem_9

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 34,407	$ 18,295
Software Products or Services Consists of aiWARE Revenues [Member]
Revenue	3,371
Software Products & Services [Member]
Revenue	18,167	$ 4,685
Software Products & Services [Member] | Pandologic Ltd [Member]
Revenue	$ 14,796

Consolidated Financial State_10

Consolidated Financial Statements Details - Schedule of Other Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Income And Expenses [Abstract]
Interest (expense) income, net	$ (1,182)	$ 2
Other	(4)	(11)
Other expense, net	$ (1,186)	$ (9)

Leases, Commitments and Conti_3

Leases, Commitments and Contingencies - Schedule of Cumulative Effects of Changes Made to the Company (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Jan. 01, 2022	Dec. 31, 2021
ASSETS
Prepaid expenses and other current assets	$ 12,519	$ 12,188	$ 12,117
Other assets	6,078	2,937	954
Total assets	469,004		504,752
Liabilities
Other accrued liabilities	22,993	28,768	27,093
Other non-current liabilities	16,440	14,135	13,078
Total liabilities	413,004		424,173
Stockholders' equity
Accumulated deficit	$ (380,076)	(351,636)	$ (350,958)
Adjustments Due to Adoption of New Leasing Standard [Member]
ASSETS
Prepaid expenses and other current assets		71
Other assets		1,983
Liabilities
Other accrued liabilities		1,675
Other non-current liabilities		1,057
Stockholders' equity
Accumulated deficit		$ (678)

Leases, Commitments and Conti_4

Leases, Commitments and Contingencies - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 28, 2021ft²	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Other Commitments [Line Items]
Operating lease, cash payments		$ 652
Operating lease, weighted average remaining lease term		2 years 8 months 12 days
Operating lease, weighted average discount rate		780.00%
Loss on disposal of property and equipment and leasehold improvements			$ (1,894)
Loss on sublease			1,211
Rent expense				$ 4,668
Minimum sublease rental income to be received in the future under noncancelable subleases				$ 3,402
Liability for potential exposure		$ 134	138
Purchase consideration payment within ten days of first anniversary of acquisition		1,500
Purchase consideration payment within ten days of second anniversary of acquisition		1,500
Office Sublease [Member]
Other Commitments [Line Items]
Area of Office Space Subleased | ft²	37,875
Lease Expiration Date	Dec. 31, 2024
Sublease charges			3,367
Loss on disposal of property and equipment and leasehold improvements			(1,894)
Loss on sublease			1,211
Initial direct costs			262
Rent expense		506	$ 571
Sublease income		277
Other Non-Current Liabilities [Member]
Other Commitments [Line Items]
Non-current portion of operating lease liabilities		$ 2,851
Minimum [Member]
Other Commitments [Line Items]
Operating lease, remaining lease term		1 year
Operating lease, renewal term		1 year
Minimum [Member] | Other Assets
Other Commitments [Line Items]
Operating lease right-of-use assets		$ 2,556
Minimum [Member] | Other Accrued Liabilities [Member]
Other Commitments [Line Items]
Current portion of operating lease liabilities		$ 2,106
Maximum [Member]
Other Commitments [Line Items]
Operating lease, remaining lease term		5 years
Operating lease, renewal term		5 years

Leases, Commitments and Conti_5

Leases, Commitments and Contingencies - Summary of Future Minimum Lease Payments (Detail) - Building Lease Agreement [Member] $ in Thousands	Dec. 31, 2021USD ($)
Other Commitments [Line Items]
2022 (nine months)	$ 2,095
2023	2,241
2024	1,792
Total future minimum lease payments, including short-term leases	6,128
Less: future minimum lease payments for short-term leases	(602)
Less: imputed interest	(569)
Present value of future minimum lease payments, excluding short-term leases	4,957
Less: current portion of operating lease liabilities	(2,106)
Non-current portion of operating lease liabilities	2,851
2022 (nine months)	782
2023	1,297
2024	1,034
Total sublease income	$ 3,113

Commitments and Contingencies -

Commitments and Contingencies - Summary of Future Minimum Lease Payments Under Previous Lease Accounting Standard (Detail) - Building Lease Agreement [Member] $ in Thousands	Dec. 31, 2021USD ($)
Other Commitments [Line Items]
2022	$ 2,532
2023	2,091
2024	1,730
Total minimum payments	$ 6,353

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Class of Stock [Line Items]
Exercise of warrants		$ 2,279
Common Stock [Member]
Class of Stock [Line Items]
Exercise of warrants		$ 2,279
Exercise of warrants issued, shares for cash consideration		167,495
Aggregate exercise of warrants issued, shares		84,723
Issued warrants to purchase shares upon exercises		91,833
Shares issued to outside service provider, shares		15,828
Common Stock [Member] | March 2022 Acquisition [Member]
Class of Stock [Line Items]
Business acquisition, shares issued or issuable	116,550
Common Stock [Member] | Pandologic Ltd [Member]
Class of Stock [Line Items]
Business acquisition, shares issued or issuable	352,330
Common Stock and Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Shares issued in connection with stock option exercise	615,703	608,886

Stock Plans - Additional Inform

Stock Plans - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Common stock were purchased under ESPP	67
Accrued employee contributions	$ 191,000
Timebased Stock Option [Member]
Class of Stock [Line Items]
Options granted	480,850
Restricted Stock Units [Member]
Class of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 14,362,000
Cost of share-based compensation awards, recognition period	2 years 2 months 4 days
Performance-based Stock Options [Member]
Class of Stock [Line Items]
Total grant date fair value of stock options granted	$ 0	$ 0
Total grant date fair value of stock options vested	0
Unrecognized compensation expense related to stock options	16,268,000
Aggregate intrinsic value of the options exercised	$ 221,000	5,815,000
Stock Options [Member]
Class of Stock [Line Items]
Options granted	291,850
Cost of share-based compensation awards, recognition period	3 years 3 months 18 days
Total grant date fair value of stock options vested	$ 1,085,000	733,000
Unrecognized compensation expense related to stock options	15,080,000
Aggregate intrinsic value of the options exercised	$ 163,000	$ 7,848,000
Weighted Average Grant Date Fair Value, Granted	$ 11.36	$ 32.68

Stock Plans - Schedule of Fair

Stock Plans - Schedule of Fair Value Assumptions (Detail) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 years 1 month 6 days
Expected volatility	82.00%
Risk-free interest rate	1.80%

Stock Plans - Summary of Fair V

Stock Plans - Summary of Fair Value Assumptions of Stock Purchase Plan (Detail) - Employee Stock Purchase Plan [Member]	3 Months Ended
	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	71.00%
Expected volatility, maximum	88.00%
Risk-free interest rate, minimum	0.20%
Risk-free interest rate, maximum	2.40%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 months
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	2 years

Stock Plans - Schedule of Stock

Stock Plans - Schedule of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 4,816	$ 21,610
Cost of Revenue [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	20
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	463	898
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	1,004	1,019
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	3,329	19,693
Restricted Stock Units [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	3,432	4,171
Stock Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		19
Performance-based Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		16,314
Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	1,273	837
Common Stock Issued for Services [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	19	119
Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 92	$ 150

Stock Plans - Schedule of Restr

Stock Plans - Schedule of Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member]	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Unvested, Beginning Balance | shares	886,461
Shares, Granted | shares	402,811
Shares, Forfeited | shares	(28,824)
Shares, Vested | shares	(328,956)
Shares, Unvested, Ending Balance | shares	931,492
Weighted Average Grant Date Fair Value, Unvested, Beginning Balance | $ / shares	$ 32.56
Weighted Average Grant Date Fair Value, Granted | $ / shares	16.47
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	23.20
Weighted Average Grant Date Fair Value, Vested | $ / shares	46.65
Weighted Average Grant Date Fair Value, Unvested, Ending Balance | $ / shares	$ 21.01

Stock Plans - Schedule of Perfo

Stock Plans - Schedule of Performance-Based Stock Options Activity (Detail) - Performance-based Stock Options [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	3,834,441
Options Exercised | shares	(21,713)
Options Expired | shares	(7,277)
Options, Outstanding, Ending Balance | shares	3,805,451
Options Exercisable at March 31, 2021 | shares	3,805,451
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 11.05
Weighted-Average Exercise Price, Options Exercised | $ / shares	5.55
Weighted-Average Exercise Price, Options Expired | $ / shares	4.94
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	11.09
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 11.09
Weighted-Average Remaining Contractual Term, Outstanding	6 years 3 months 18 days
Weighted-Average Remaining Exercisable	6 years 3 months 18 days
Weighted-Average Aggregate Intrinsic Value | $	$ 27,350
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 27,350

Stock Plans - Schedule of Sto_2

Stock Plans - Schedule of Stock Option Activity (Detail) - Stock Options [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	5,508,608
Options Granted | shares	291,850
Options Exercised | shares	(20,222)
Options Forfeited | shares	(57,134)
Options Expired | shares	(8,425)
Options, Outstanding, Ending Balance | shares	5,714,677
Options Exercisable at March 31, 2021 | shares	4,289,264
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 15.10
Weighted-Average Exercise Price, Options Granted | $ / shares	16.13
Weighted-Average Exercise Price, Options Exercised | $ / shares	7.33
Weighted-Average Exercise Price, Options Forfeited | $ / shares	13.07
Weighted-Average Exercise Price, Options Expired | $ / shares	21.61
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	15.23
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 13.76
Weighted-Average Remaining Contractual Term, Outstanding	6 years 2 months 12 days
Weighted-Average Remaining Exercisable	5 years 4 months 24 days
Weighted-Average Aggregate Intrinsic Value | $	$ 25,419
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 20,201

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Related Party Transactions [Abstract]
Due to related party transactions	$ 0	$ 0